Really proud of this special issue convened by @Peter_Aldiss and I, with the support of @ThePhySoc, on the physiology of obesity. Stay tuned for part 2.

I am excited to share our latest paper @Nature where we construct a hi-res spatial map of the human hypothalamus, the brain region central in appetite control. It is a collaboration between @IMS_MRL @Cambridge_Uni & @MPI_Metabolism https://t.co/04ZLrCDJ2N

CAN'T WAIT for our (@cld536) @ThePhySoc meeting in July. Speakers inc. @Hodson_Group @joedwardlewis @lab_cota @TonyGoldstone @Roberts_Lab @BarteltLab @blaak_e @echouchani & more. We also have 15x ECR talks + posters so make sure you register and submit! https://t.co/g3zPuBXYIO

SAVE THE DATE The 1st in-person Physiology of Obesity M2M with @ThePhySoc 8-9th July '25 @UniofNottingham Exciting speakers inc. @joedwardlewis @TonyGoldstone @Roberts_Lab @BarteltLab @echouchani @fionamcgill_UCD confirmed & will be 15x ECR slots! https://t.co/XYyqvNYIH3

Our latest on understanding GIP agonism v antagonism. Shout out to @TimoMueller_IDO since lots of this work replicated work from his group. We tried to take it a little farther. Genetic loss of GIP signaling in CNS increases weight loss to GLP-1 agonists. 💪

Absolutely delighted to have my latest paper out in @AGA_Gastro with @MetteK_And and @damato_mauro https://t.co/Ksz0H3jAFZ And absolutely wild to have it picked up by the @Independent https://t.co/IVjNIAHzvz And by the @newyorkpost https://t.co/z6DA5kX32V

Good news! Our revue "Physiology of physical inactivity, sedentary behaviours and non-exercise activity: insights from the space bedrest model" received enough citations to be a #TopCitedArticle in @JPhysiol ☺️ @A_Bergouignan @natedejong115 https://t.co/Wp2tNTRgET

Drugs like Ozempic are great for weight loss, but they make some people feel sick. We discovered that the brain circuits mediating the appetite suppression are distinct from those that mediate nausea – a finding that may be leveraged to develop more selective GLP1-based drugs.

𝐌𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐬𝐦 𝐢𝐧 𝐀𝐜𝐭𝐢𝐨𝐧 ⌚ 𝘛𝘪𝘮𝘦 🌌 𝘚𝘱𝘢𝘤𝘦 👩‍⚕️ 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 We are excited to announce that the application period is now open for Metabolism in Action 2024! The @ScienceCluster conference on November 18-22 will bring together leading experts with the

Often people will say, X food or activity increases GLP1, but in this Huberman Lab episode out now @zaknight explains why enormous increases in GLP1 are necessary for weight loss; increases that pharmacology alone can produce. It’s also a master class in the control of hunger.

Congrats to @joedwardlewis on the fascinating model and findings in which DREADD-activated endogenous GIP secretion reduces food intake and body weight in DIO mice. https://t.co/DBVA1ZF2Pu

Targeting gut endocrine cells is a logical yet challenging therapeutic target with small molecule GLP1RAs looming. Here the team @CamMetaboNet uses chemogentics to link K cells to reduction of food intake @MolMetab https://t.co/6kJDIVoniT #weightloss

Very happy to see this research finally out. https://t.co/hN2WjnElc9 Hats off to @LoraHeisler @GilesYeo @gkcdowsett and Xless Antonio Gonzalez, Sergiy Sylantyev and Yuliia Martynova for their support.

Check out our latest research - A brainstem to hypothalamic arcuate nucleus GABAergic circuit drives feeding: Current Biology

New pre-print out on the development and characterisation of a novel #FGF21 KO rat for #MASH and alcohol intake. Delighted to share some work from my @DDEA_Denmark fellowship with @MatthewGillum6 @Metabolcenter and a wonderful collab with Gubra. https://t.co/Uvi1krpO4h

PLEASE RT/SHARE Finally recruiting a Postdoc RA/Fellow to the group to do some human work on FGF21 and alcohol intake/preference. Neuroimaging experience preferred but please get in touch if interested! https://t.co/4jYErQHXPQ

Only 10 days to the registration and abstract deadline - don't delay - sign up today 👇👇👇👇👇 5th Incretin Study Group Meeting 4-6 April 2024, Cambridge https://t.co/eOqL1N4Ytm

Nausea and vomiting in pregnancy linked to hormone from fetus https://t.co/TI7psoCsAr Thanks to Alice and Rachel for this very nice News and Views !

BSN ANNUAL MEETING - Save the date! 1-3 July 2024 Get ready to join us at #Aberdeen2024 – our annual meeting will highlight the latest neuroendocrinology research with a strong focus on our early-career researchers. More info: https://t.co/qOuzJf6tcy

1/ So, @UniofNottingham are recruiting this years intake of 'Nottingham Fellows'. You get the chance to start your own independent group, with 3y research time on 'Tenure Track' leading to a permanent R&T post as Asst Prof. PLEASE RT https://t.co/6vdN2aiEuj

We’re thrilled to share our preprint (collab with @marionilab) in which we use human POMC neurons to identify potential anti-obesity drugs, one of which seems to increase the efficacy of Semaglutide (Ozempic). Details on BioRxiv: https://t.co/lkdYYhFDq7. Thread below 🧵(1/16)